Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I'm in from long time ago, no real choice but to hold.
I hate to say this but I think you are going to get more angry as the days go on if we don't get huge sales news soon.
I know how you feel. I am holding shares I bought at $20 (R/S adjusted)...Just trying to help people not make the same mistake I did. View all positve sounding posts, after the spike, skeptically. Remember, it is likely that they missed the move, and will use any upward moves to save face or to bail out, or just don't know as much as they think they do.
As I said before, posting links to recent news and interviews does not constitute DD.
You have to go back and research and review the reasons behind the moves in the chart. If this had not R/S and would still be at .22/share, (down from 1.00), would you feel safe putting your money in? Especially after the much touted CEmark and FDA news are already out? What will drive this stock higher from here? Whether it be a short term spike or more sustained move? I see nothing in the immediate future.
If we don't get any news I see us sliding to 3.90-4.00 (currently $5.42) in the next week or two. Production and sales news would be a boost. There may be a move higher to 6.00 in a last attempt to move higher but I don't see it holding.
With the money they are raising I hope that means production of the ReStore will be ramping up soon.
unfortunately, not the pop we were looking for...more like a bubble pop...at lows of the day at 5.40
missed that one
Looking at the 52 week chart, we look to be forming a base and the last time the 50 day crossed under the 200 day was where we began a steady run upward of +1.25...can we see that again?... Come on, get us back to $2.50 ...I recently picked up 1000 more at 1.38, if I had more cash I would buy again here
What does that mean exactly? $8, $10, $20/share and for how long 2 minutes, a day, a month? As of right now we are 18+% farther from the moon. As I said before , they were saying that from Nov '18 to Jun'19 on the speculation that we would get CE mark and FDA approval. Well that news has come and gone and we are still lower than when the speculation first began. .22 pre-R/S level. And that moon shot everyone was talking about and most were not here to see , lasted minutes and fell back to earth within hours. Now there is no catalyst to cause a spike to $10 let alone $20 and I will wager that there is even more dilution coming.
I doubt it, I don't think it was a buy, it was part of compensation package.
I doubt it, I don't think it was a buy, it was part of compensation package.
I would be curious to see the next quarters filings to see if Sabby Management, Ionic Ventures, Intracoastal Capital and Anson Funds Management dumped their shares during that spike.
Priced into stock long time ago
Sorry to say, but I fully expected that (as you can read in my previous post)...I have been in this stock for a good while and this is typical. I have to laugh though at all the posts that came out yesterday (mostly on other boards) about the DD they have done and how the stock is going up from here (that was at $9.00). DD is not reading the latest headlines or last couple of days worth of message board posts. It also is not listening to Mr. Jasinski and his cheerleading interviews. All those geniuses will not tell you how they just got taken to the woodshed.
While the CE mark and FDA approval are both good news, this company will still need to raise more cash and dilute. The shorts realize that. Also, now there is no catalysts to look forward to. Any new product is way down the line. Good earnings is the only thing that can get this moving steadily upward, and I don't see that happing for several quarters.
People thought I was an idiot when I said CE and FDA would get us to $5 if we were lucky and no where near $10. I was talking about a sustained PPS not a one time day trader driven spike. The good news simply comes too slowly to keep up with all the offerings and dilution needed to stay afloat until they can actually start seeing revenue from the ReStore product.
So, where did we close today?
yeah, me. Been here since .80 pre-R/S
Oh, and welcome to all the new bagholders who bought at $8 and above.
Ok, we had our "irrational exuberance" short lived spike (minutes) to above $10, now reality is setting in. Without any catalysts on the horizon and the rate they ares till using money I see us slide back toward $5. A release of some kind of news would change that but I still see more offerings/dilution coming. News of ReStore device contract would be nice. Buyout would be great for newer shareholders but for us still holding the bag, we need something to get us to $20 plus/share. I don't see that happening within 6 mos. I am talking sustained PPS.
This move is great but keep it in perspective...we have now gotten both pieces of news that everyone was looking for and we are still only back to the highs of a couple months ago when everyone was saying the news would send it to the moon from that point. I hope this move has another $10/share in it...I would finally be above water.
That would be great, then I would finally be above break even. I bought way back when it was .80, then some at .50 and a little more at .24
I have to admit I didn't think this day would come and I am still wondering if it can hold.
We are back to where we were before the CE mark news came out, like I said. Back in Nov. the CE Mark and FDA news were supposed to drive this thing skyward. 1/2 the news is out and we are below the lows back then. We will be lucky if FDA news pushes this above $5, forget seeing $10 or above any time soon.
10+% short term move is not bad, but you all know I buy and hold, looking for 100% then may take some profit and save for the next dip. Been doing this for years with EKSO. Just have to be patient through the drops, add if you can and then be patient again for the move upward.
Just picked up another 1000 shares at 1.38 for a total of 6,190 shares...buying at these moves has ALWAYS paid off for me with EKSO
While nothing in that statement is incorrect, I believe the "market" has already factored that into the PPS and it's outlook toward RWLK. It seems that the feeling is "too little, too late". The longer it drags on with no confirmed approval, the more cash is burned, without production started.
As for the stroke market and the new device. What people have to remember is that although that market is huge, the devices only apply to and can be utilized in a portion of that market, for several reasons. On top of that the patient then has to run the insurance coverage gaunlet, which is a time consuming process. I don't think there will be a sudden, quick acceptance by the insurance industries,(for the 6.0 device) which everyone seems to be using as a catalyst for the stock's PPS. They may come onboard on a case-by-case basis over a few years.
While a PR of CE or FDA approval may cause a spike in PPS, I believe RWLK has A LOT of bailing to keep this ship afloat.
I own shares at $20, $12.50 and $6 (split adjusted), so I hope I am wrong.
May be op for a swing trade here if your into that. I don't have the funds or the guts to play that.
What major news announcements? If you are referring to the Form 4 filings, they are just required forms stating that those individuals received shares as salary/compensation.
They do not mean that those individuals felt confident in the company and purchased shares. Big difference. That's why that was not major news.
If all those individuals had PURCHASED shares, that would be more newsworthy
Looks like Levitate Airframe
Correct me if I am wrong. These are NOT insider PURCHASES, they are awarded as salary or compensation. I agree that if insiders buy that infers confidence in the company and they would tend to hold the shares for some time. Shares received as salary do not necessarily infer insider confidence, they can turn around and dump the shares.
This article is not about RWLK but an exo device being used by a polio patient (looks like from 2015)
http://home.bt.com/tech-gadgets/future-tech/man-struck-by-polio-as-a-child-hopes-to-walk-naturally-thanks-to-revolutionary-bionic-leg-11363959733116
https://www.ottobock.co.uk/information-pages/news_and_media_home/news_detail_30848.html
I believe ottobock has ties to/agreements with EKSO bionics
This is from an article dated 25 Mar '19 about 2018 Life Sciences Securities Litigation Roundup
4. Post-Approval Compliance Issues
a. Post-Market Surveillance
Even after approval, life sciences companies faced challenges (and securities class actions) with respect to launching their products and testing them in the real-world. In ReWalk Robotics, a newly-public company repeatedly failed to timely respond to the FDA’s requirement of post-market surveillance studies to address safety concerns relating to its medical device and faced Section 10(b) and Section 11 claims. Because the plaintiff lacked standing (under Section 11) however, the decision in the case was deferred while a new plaintiff was sought.
I believe it was a ReWalk 6.0 not an EKSO
What a joke headline...the stock was up briefly in pre-market with 6,000 shares traded, and declined immediately upon market open.
*ReWalk Robotics shares are trading higher after the company announced it had delivered ReWalk Personal 6.0 System to Lucy Dodd which will allow her to stand and walk again.
Benzinga
Not to mention they had to fundraise to get the money to pay for it...no insurance coverage. It is great for her that she will be able to be upright and mobile, but she is not walking, the device is doing the work, she is a passenger. IMO, the insurance companies are not going to fully cover the devices until RWLK demonstrates that they move the patient toward walking on their own. Thus, the case by case basis.
A great story for the woman and her family but it means very little for the companies future.
This article highlights the problem with the device (without actually mentioning it). The cost was not covered by insurance, they had to raise the money via fundraising. Not everyone who could benefit from the device can raise the funds.
I believe a major difference between RWLK and EKSO is that EKSO is not solely concerned with just getting a person "walking" (where the device does all the work). They are focusing on rehabilitating the patients so they can eventually walk with less help from the device or completely on their own.
While getting a person upright and standing at eye level has physical and emotional benefits, the device is much too expensive to basically make the wearer just a passenger. (which is what I feel RWLK is doing)
The new device (ReStore) is less expensive, and will aid patients who can already walk with some other device. While it is a less expensive device, that means they must find more customers.
I really do not think the ReStore device is enough to save this company and keep it afloat until they develop new and more advanced products.
While ReStore may be a good product, technology and competition is constantly evolving and making previous devices obsolete. It is my opinion that RWLK as managed currently cannot keep up. They will continue to need more funding for improvements or outright new devices or technologies, never being profitable.
I bought 124 shares in '15 and 170 in '17. Now have 409 shares using DRIP. Also seems to have a pretty predictable range. 18.50 being a good buy point and 17.00-17.25 the rock bottom buy point. Looks to be at it high right now though.